Catalyst Wire Dossier Catalyst Wire Dossier

EC followed by Docetaxel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EC followed by Docetaxel, covering 2019-10-25 to 2019-10-25. Get the full timeline:

Most recent: Clinical Trial Update: EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer [Phase 3]

See pricing